HRTX R&D Expenses
Heron Therapeutics Inc · R&D Expenses
HRTX R&D Expenses
Latest reported$12.30Mperiod ending
HRTX TTM R&D Expenses ($0.00 → $12.30M)
TTM R&D Expenses
High-resolution chart · PNG
HRTX r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 12,303,000 | |
| 12,535,000 | |
| 12,429,000 | |
| 11,861,000 | |
| 12,856,000 | |
| 14,354,000 | |
| 16,683,000 | |
| 24,455,000 | |
| 33,548,000 | |
| 42,326,000 | |
| 46,554,000 | |
| 46,661,000 | |
| 58,648,000 | |
| 74,272,000 | |
| 107,506,000 | |
| 125,326,000 | |
| 128,376,000 | |
| 134,775,000 | |
| 130,821,000 | |
| 146,397,000 | |
| 166,984,000 | |
| 175,755,000 | |
| 174,533,000 | |
| 178,357,000 | |
| 163,883,000 | |
| 161,304,000 | |
| 167,382,000 | |
| 158,996,000 | |
| 154,709,000 | |
| 143,443,000 | |
| 140,032,000 | |
| 147,898,000 | |
| 146,321,000 | |
| 144,759,000 | |
| 138,582,000 | |
| 120,330,000 | |
| 121,728,000 | |
| 120,417,000 | |
| 103,125,000 | |
| 89,883,000 | |
| 73,882,000 | |
| 62,771,000 | |
| 61,183,000 | |
| 59,115,000 | |
| 59,605,000 | |
| 57,857,000 | |
| 55,124,000 | |
| 50,521,000 | |
| 42,006,000 | |
| 38,110,000 | |
| 33,111,000 | |
| 28,542,000 | |
| 25,952,000 | |
| 18,488,000 | |
| 15,045,000 | |
| 12,877,000 | |
| 12,180,000 | |
| 10,395,000 | |
| 8,207,000 | |
| 6,854,000 | |
| 5,466,000 | |
| 6,074,000 | |
| 7,264,000 | |
| 7,182,000 | |
| 7,059,000 | |
| 8,077,000 | |
| 7,796,000 | |
| 9,136,000 | |
| 12,787,000 | |
| 15,417,000 | |
| 19,507,000 | |
| 22,767,000 | |
| 22,293,000 | |
| 20,518,000 | |
| 19,365,000 | |
| 18,138,000 | |
| 16,661,000 | |
| 16,754,000 | |
| 15,236,000 | |
| 13,537,000 | |
| 12,725,000 | |
| 11,947,000 | |
| 10,300,000 | |
| 10,046,000 | |
| 10,262,000 | |
| 10,089,000 | |
| 11,302,000 | |
| 10,731,000 | |
| 10,063,000 | |
| 9,493,000 | |
| 8,660,000 | |
| 7,847,000 | |
| 7,867,000 | |
| 7,404,000 | |
| 6,699,000 | |
| 7,682,000 | |
| 7,795,000 | |
| 7,467,000 | |
| 7,348,000 | |
| 6,427,000 |